celecoxib 200 MG Oral Capsule [Celebrex]

RxCUI
213469
RxNorm name
celecoxib 200 MG Oral Capsule [Celebrex]
Display name
CeleBREX (Oral Pill)
Full name
celecoxib 200 MG Oral Capsule [Celebrex]
Term type
SBD
Status
Active
Strength
200 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-11-14 08:24:41

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
042005
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
celecoxib200 MG / 1 EACHcelecoxibcelecoxib

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
celecoxib140587

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRCeleBREX 200 MG Oral Capsule1NAMES
RxNorm Namecelecoxib 200 MG Oral Capsule [Celebrex]1NAMES
RxNorm SynonymCelebrex 200 MG Oral Capsule1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI2134691CODES
MMSL_CODEBD68651CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
58151-084-0158151-084CELEBREX CelecoxibViatris Specialty LLCNDA020998
58151-084-0558151-084CELEBREX CelecoxibViatris Specialty LLCNDA020998
58151-084-8858151-084CELEBREX CelecoxibViatris Specialty LLCNDA020998

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA02099858151-084CELEBREX CelecoxibNDAViatris Specialty LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 3 · 264 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00025152531rxnav_ndcsyes
00025152534rxnav_ndcsyes
00025152551rxnav_ndcsyes
12634083471rxnav_ndcsyes
33261001910rxnav_ndcsyes
50436760201rxnav_ndcsyes
50436760202rxnav_ndcsyes
52959053900rxnav_ndcsyes
52959053921rxnav_ndcsyes
55289047528rxnav_ndcsyes
58151008401rxnav_ndcsyes
58151008405rxnav_ndcsyes
58151008432rxnav_ndcsyes
58151008488rxnav_ndcsyes
58864070930rxnav_ndcsyes
60760052520rxnav_ndcsyes
60760052530rxnav_ndcsyes
60760052560rxnav_ndcsyes
61919004630rxnav_ndcsyes
61919004660rxnav_ndcsyes
63629302100rxnav_ndcsyes
63629302101rxnav_ndcsyes
63629302102rxnav_ndcsyes
63629302103rxnav_ndcsyes
63629302104rxnav_ndcsyes
63629302105rxnav_ndcsyes
63629302106rxnav_ndcsyes
63629302107rxnav_ndcsyes
63629302108rxnav_ndcsyes
63629302109rxnav_ndcsyes
66105010603rxnav_ndcsyes
66105010610rxnav_ndcsyes
66267004807rxnav_ndcsyes
66267004810rxnav_ndcsyes
66267004815rxnav_ndcsyes
66267004820rxnav_ndcsyes
66267004830rxnav_ndcsyes
66267004856rxnav_ndcsyes
66267004860rxnav_ndcsyes
66336072730rxnav_ndcsyes
00025152596rxnav_historical
00025152598rxnav_historical
00025152599rxnav_historical
00247181000rxnav_historical
00247181007rxnav_historical
00247181010rxnav_historical
00247181015rxnav_historical
00247181020rxnav_historical
00247181030rxnav_historical
00440724030rxnav_historical
00615134805rxnav_historical
00615134831rxnav_historical
00615134839rxnav_historical
00615134863rxnav_historical
10544030530rxnav_historical
12634083400rxnav_historical
12634083401rxnav_historical
12634083414rxnav_historical
12634083480rxnav_historical
12634083484rxnav_historical
12634083491rxnav_historical
16590004610rxnav_historical
16590004614rxnav_historical
16590004615rxnav_historical
16590004620rxnav_historical
16590004628rxnav_historical
16590004630rxnav_historical
16590004656rxnav_historical
16590004660rxnav_historical
16590004662rxnav_historical
16590004682rxnav_historical
16590004690rxnav_historical
18837002430rxnav_historical
18837002460rxnav_historical
18837023720rxnav_historical
18837023730rxnav_historical
18837023760rxnav_historical
18837023790rxnav_historical
18837023796rxnav_historical
21695002310rxnav_historical
21695002314rxnav_historical
21695002315rxnav_historical
21695002320rxnav_historical
21695002328rxnav_historical
21695002330rxnav_historical
21695002360rxnav_historical
23490727400rxnav_historical
23490727401rxnav_historical
23490727402rxnav_historical
23490727403rxnav_historical
23490727404rxnav_historical
23490727405rxnav_historical
23490727407rxnav_historical
26053009501rxnav_historical
33261001900rxnav_historical
33261001902rxnav_historical
33261001907rxnav_historical
33261001914rxnav_historical
33261001915rxnav_historical
33261001920rxnav_historical
33261001921rxnav_historical
33261001928rxnav_historical
33261001930rxnav_historical
33261001934rxnav_historical
33261001960rxnav_historical
33261001990rxnav_historical
33358007010rxnav_historical
33358007014rxnav_historical
33358007015rxnav_historical
33358007020rxnav_historical
33358007030rxnav_historical
33358007060rxnav_historical
33358007090rxnav_historical
42549050530rxnav_historical
42549050560rxnav_historical
47463006400rxnav_historical
47463006430rxnav_historical
47463006460rxnav_historical
47463006490rxnav_historical
49349087202rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CELEBREXCELECOXIBViatris Specialty LLC2d6675e4-5859-4be2-8037-a20ce9f707aa2024-11-22Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 58151-084-01
ndc (package): 58151-084-05
ndc (package): 58151-084-88
ndc (product): 58151-084
ndc11 (package): 58151008401
ndc11 (package): 58151008405
ndc11 (package): 58151008432
ndc11 (package): 58151008488
rxcui: 213469

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2d6675e4-5859-4be2-8037-a20ce9f707aaCeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]313These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 199820241122
73eb9256-dcda-4eb1-8a6e-700522146f2eCeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]35These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820150505
925b0408-2ba4-4d4c-a1cd-ddfa7115234dCeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]33These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820120127
b6bd0101-ebf0-43e8-99bf-21cb032b05d6CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]33These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820111214
05cf80f2-12a0-46b0-bcb7-1c982ed7bd3eCeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]32These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820140703
e3591a83-fbb4-4679-89f0-ce3a2331ed54CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]32These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820110513
e082d783-793f-4c17-b124-04fe377fb272CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]31These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820140820
814511c9-89ef-42d7-912e-c00147833b7eCeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]31These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820120912
bff7e0aa-0c01-4f6e-89ed-da27cc36706eCeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]31These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820110606
14e50e10-bbe0-4a2c-983a-19bfa79bdef7CeleBREX 200 MG Oral Capsule [PSN] · celecoxib 200 MG Oral Capsule [Celebrex] [SBD] · Celebrex 200 MG Oral Capsule [SY]31These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 199820090710

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f2f090c2-3ee1-7689-e053-2995a90abe38These highlights do not include all the information needed to use LEVOFLOXACIN TABLETS safely and effectively. See full prescribing information for LEVOFLOXACIN TABLETS. LEVOFLOXACIN tablets, for oral use Initial U.S. Approval: 1996Northwind Health Company, LLC20260101
a6854053-029c-419f-8c79-8b59a2600fa1These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998PD-Rx Pharmaceuticals, Inc.20220311
8d52185d-421f-4e34-8db7-f7676db2a226These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules, for oral use Initial U.S. Approval: 1998PFIZER LABORATORIES DIV PFIZER INC20210415
9f9dd7b9-a072-46d0-a8b5-b3e138c85f1cThese highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998Proficient Rx LP20210101
a645dfcd-7343-4c79-af8b-1117e4a5b113CELEBREXDirect Rx20191014
fe16ecb3-621c-4dbb-92e6-9e636b75ab84These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998Cardinal Health20150428
e082d783-793f-4c17-b124-04fe377fb272These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998Preferred Pharmaceuticals, Inc.20140820
906d08ee-cf5b-41f7-b2d4-73179f7d74f0National Council for Prescription Drug Programs20130213
c1bc6c14-bc07-4dce-8b1d-fd9db891244fNational Council for Prescription Drug Programs20120724
b6e129fd-3d10-4038-b267-f9383b6a4c84National Council for Prescription Drug Programs20120724
c21b0501-da1a-438b-9afb-ad818c17ce6fNational Council for Prescription Drug Programs20120724
c48b96dc-21f9-48d5-bf5f-69781d33cfcbNational Council for Prescription Drug Programs20120724
cccc9f59-6a98-4cc0-bc36-2a84ccf0754eNational Council for Prescription Drug Programs20120724
da3a2edb-5542-4bff-8718-58ea39d0d34fNational Council for Prescription Drug Programs20120724
e84eaf7b-51ec-4744-87d1-0a3393cc878cNational Council for Prescription Drug Programs20120724
ec748824-16e5-4ef9-978d-a8d51b192215National Council for Prescription Drug Programs20120724
f33effac-8d1b-48da-bebf-b6a0e2c0ac60National Council for Prescription Drug Programs20120724
f391c515-541e-4a7f-8857-65a8bfdd483aNational Council for Prescription Drug Programs20120724
f8a4d297-7820-48d0-9cf7-c0247ec534edNational Council for Prescription Drug Programs20120724
f9ee868f-1221-42cf-98fd-25e70adf531cNational Council for Prescription Drug Programs20120724
fc0eef74-893c-43b6-8f5d-83ac8090bdc4National Council for Prescription Drug Programs20120724
fffda792-18ff-470c-aeb6-d0481c2fe9d8National Council for Prescription Drug Programs20120724
a1df2611-e6a3-4770-8bd6-a853cb04ae4aNational Council for Prescription Drug Programs20120724
8b7d24e6-0730-4777-8e8b-c801c5b2ec2fNational Council for Prescription Drug Programs20120724
8e11492f-e981-463b-afe2-3dc5b8382e1eNational Council for Prescription Drug Programs20120724
901bdc30-b797-47c0-93d6-9bd65289a5a4National Council for Prescription Drug Programs20120724
93519f0f-867e-4d6d-9d07-999375b0f5cbNational Council for Prescription Drug Programs20120724
935ae5a2-d228-48bd-adc8-78802a8dfef5National Council for Prescription Drug Programs20120724
9a35d96a-5aa3-4efe-95f9-39bcb79a2cacNational Council for Prescription Drug Programs20120724
9eb4d7e9-2fc2-420f-b8ed-7013d691a67fNational Council for Prescription Drug Programs20120724
a4121ee1-ebc7-4fbc-a91d-a6d2081d51a6National Council for Prescription Drug Programs20120724
a6132694-1737-4d59-9474-31d11ecbffb1National Council for Prescription Drug Programs20120724
ad6d289a-741e-406e-94bd-272a870363c5National Council for Prescription Drug Programs20120724
b2e1b572-c51e-4162-aa4b-d45a5be07132National Council for Prescription Drug Programs20120724
88690826-0cc7-4b18-8d5f-b8516429c248National Council for Prescription Drug Programs20120724
bbee4223-9481-42d2-821c-bbc71b56f1d0National Council for Prescription Drug Programs20120724
925b0408-2ba4-4d4c-a1cd-ddfa7115234dThese highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998STAT Rx USA LLC | PSS World Medical Inc20120127
b6bd0101-ebf0-43e8-99bf-21cb032b05d6These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998H.J. Harkins Company, Inc. | G.D. Searle LLC Division of Pfizer Inc | Pfizer Pharmaceuticals LLC | Pfizer Asia Pacific PTE LTD20111214
bff7e0aa-0c01-4f6e-89ed-da27cc36706eThese highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998Keltman Pharmaceuticals Inc.20110606
e3591a83-fbb4-4679-89f0-ce3a2331ed54These highlights do not include all the information needed to use CELEBREX safely and effectively. See full prescribing information for CELEBREX. CELEBREX ® (celecoxib) capsules Initial U.S. Approval: 1998STAT RX USA LLC20110513

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCM01AHCoxibsATC1-4celecoxib
ATCL01XXOther antineoplastic agentsATC1-4celecoxib
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epccelecoxib
FDASPLN0000000160Cyclooxygenase InhibitorsMOAhas_moacelecoxib
MEDRTD000068579CelecoxibCHEMhas_ingredientcelecoxib
MEDRTD011125Adenomatous Polyposis ColiDISEASEmay_treatcelecoxib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treatcelecoxib
MEDRTD004342Drug HypersensitivityDISEASEci_withcelecoxib
MEDRTD004412DysmenorrheaDISEASEmay_treatcelecoxib
MEDRTD010003OsteoarthritisDISEASEmay_treatcelecoxib
MEDRTD011247PregnancyDISEASEci_withcelecoxib
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatcelecoxib
MEDRTN0000008288Cyclooxygenase 2 InhibitorsMOAhas_moacelecoxib
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pecelecoxib
MEDRTN0000000045Fecal ExcretionPKhas_pkcelecoxib
MEDRTN0000000026Hepatic MetabolismPKhas_pkcelecoxib
MEDRTN0000000042Renal ExcretionPKhas_pkcelecoxib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH200 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA020998
NAMESPrescribable SynonymCeleBREX 200 MG Oral Capsule
NAMESTallman SynonymCeleBREX 200 MG Oral Capsule
NAMESTallman Synonymcelecoxib 200 MG Oral Capsule [CeleBREX]
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon